Tag: Pharmaceutical

APLANTEX
Global, United States

Frederick Perrault Joins Aplantex’s Board of Directors

MONTRÉAL–(BUSINESS WIRE)–Mr. Patrick Charest, B. Sc., P. Eng., CEO of Aplantex, is pleased to announce the arrival of Mr. Frédérick Perrault, CPA, CA, M. Sc., as an investor, strategic advisor, and member of the company’s board of directors. “We are very proud to welcome this expert in financial, strategic, and governance management focused on innovation and growth,” said Mr. Charest. “His valuable contribution will help … Continue reading Frederick Perrault Joins Aplantex’s Board of Directors

Impact Newswire
CDISC
Global, United States

CDISC Names Chris Decker President and CEO

AUSTIN, Texas–(BUSINESS WIRE)–CDISC announces industry veteran Chris Decker is joining the organization as its new President and Chief Executive Officer effective January 2, 2024, succeeding Dave Evans who will be transitioning into retirement after decades of outstanding service to CDISC. Chris is recognized industry wide as a leading technology and standards expert for designing, developing, and implementing complex process and technology solutions. He brings years … Continue reading CDISC Names Chris Decker President and CEO

Impact Newswire
Elligo Health Research
Global, United States

Elligo Health Research Announces New CEO

John Potthoff Transitions to Chairman, Barry Simms Promoted to CEO AUSTIN, Texas–(BUSINESS WIRE)–Elligo Health Research®, the largest healthcare-enabling research organization, today announced that Elligo’s Founder and CEO, John Potthoff, Ph.D., transitioned his leadership to COO, Barry Simms. Potthoff will assume the role of Elligo’s Chairman, while Simms’ responsibilities will change to driving strategic direction as CEO — guiding the team and customers to make research as care … Continue reading Elligo Health Research Announces New CEO

Impact Newswire
PFIZER
Global, United States

Pfizer Completes Acquisition of Seagen

NEW YORK–(BUSINESS WIRE)–Pfizer Inc. (NYSE: PFE) today announced the successful completion of its acquisition of Seagen Inc. (NASDAQ: SGEN), a global biotechnology company that discovers, develops and commercializes transformative cancer medicines. Pfizer completed its acquisition of all outstanding common stock of Seagen for $229 in cash per share, for a total enterprise value of approximately $43 billion. “Cancer remains a leading cause of death, and … Continue reading Pfizer Completes Acquisition of Seagen

Impact Newswire
NUCLEUS RADIOPHARMA
Global, United States

Nucleus RadioPharma Appoints Former McKesson, Novo Nordisk Executive Kathy Spencer-Pike as Chief Commercial Officer to Drive Business Growth

Kathy Spencer-Pike brings more than two decades of experience within highly matrixed Fortune 50 environments as well as fast-paced growth and start-up enterprises ROCHESTER, Minn.–(BUSINESS WIRE)–Nucleus RadioPharma, the world’s first fully integrated development, manufacturing, and supply chain organization for radiopharmaceuticals, today announced the appointment of Kathy Spencer-Pike as Chief Commercial Officer. As a seasoned veteran with decades of commercial experience at McKesson, Novo Nordisk, Sanofi … Continue reading Nucleus RadioPharma Appoints Former McKesson, Novo Nordisk Executive Kathy Spencer-Pike as Chief Commercial Officer to Drive Business Growth

Impact Newswire
AOP Health
Europe, Global

AOP Health Receives Market Authorization for Landiolol in Canada

December 13, 2023 08:55 AM Eastern Standard Time VIENNA–(BUSINESS WIRE)–At the end of November 2023, AOP Orphan Pharmaceuticals GmbH (AOP Health), an Austrian pharmaceutical company based in Vienna, received authorization from the Canadian Health Authority (Health Canada) for its ultra-short-acting, cardioselective β1-blocker Landiolol. The drug is used in intensive care to treat atrial fibrillation and atrial flutter (supraventricular tachycardia) and non-compensatory sinus tachycardia, hence when … Continue reading AOP Health Receives Market Authorization for Landiolol in Canada

Impact Newswire
NUCLEUS RADIOPHARMA
Global, United States

Nucleus RadioPharma Appoints Industry Veteran Mark Przekop as Chief Operating Officer to Lead Supply Chain Strategy

Mark Przekop brings over 35 years of radiopharmaceuticals commercialization and development experience from ARTMS and Jubilant Radiopharma December 07, 2023 07:15 AM Eastern Standard Time ROCHESTER, Minn.–(BUSINESS WIRE)–Nucleus RadioPharma, the world’s first fully integrated development, manufacturing, and supply chain organization for radiopharmaceuticals, today announced the expansion of its executive leadership team with Mark Przekop joining as Chief Operating Officer. As a veteran with over 35 … Continue reading Nucleus RadioPharma Appoints Industry Veteran Mark Przekop as Chief Operating Officer to Lead Supply Chain Strategy

Impact Newswire
Alentis Therapeutics
Europe, Global

Alentis Therapeutics Expands Leadership Team with the Appointment of Rizwan Velji as Chief Business Officer

Velji brings more than 20 years of experience in biotech financial services December 06, 2023 08:00 AM Eastern Standard Time BASEL, Switzerland–(BUSINESS WIRE)–Alentis Therapeutics (“Alentis”), a clinical-stage biotechnology company developing treatments for Claudin-1 positive (CLDN1+) tumors and organ fibrosis, today announced that Rizwan Velji has been appointed Chief Business Officer (CBO). He will lead corporate strategy, business development, and finance. Rizwan Velji, Chief Business Officer … Continue reading Alentis Therapeutics Expands Leadership Team with the Appointment of Rizwan Velji as Chief Business Officer

Impact Newswire